Amphastar Pharmaceuticals, Inc. (AMPH)
NGS · Common · CUSIP 03209R103
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for AMPH and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
03209R103
Market Cap
Mid Cap · $952 Million
IPO
6/24/2014 · $7.00/share
Business: Amphastar Pharmaceuticals, Inc. is a biopharmaceutical company that is engaged in the development, manufacture and marketing of generic and proprietary injectable, intranasal and inhalation products.

Company Contact

CEO
Jack Yongfeng Zhang, Ph.D.
CFO
William J. Peters
Headquarters
11570 6th Street, Rancho Cucamonga, CA 91730
Phone
909-980-9484
Investor Relations
Bill Peters · 909-476-3416
Email Form
Contact Form »
SEC EDGAR Filings
View filings »